Veracyte, Inc. (VCYT) is a publicly traded Healthcare sector company. As of July 15, 2026, VCYT trades at $57.20 with a market cap of $4.59B and a P/E ratio of 50.86. VCYT moved +1.02% today. Year to date, VCYT is +34.49%; over the trailing twelve months it is +112.46%. Its 52-week range spans $22.61 to $60.91. Analyst consensus is buy with an average price target of $55.43. Rallies surfaces VCYT's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks politician and congressional stock disclosures for VCYT, including purchases, sales, transaction dates, owners, and reported trade amounts when available.
| Metric | Value |
|---|---|
| Price | $57.20 |
| Market Cap | $4.59B |
| P/E Ratio | 50.86 |
| EPS | $1.11 |
| Dividend Yield | 0.00% |
| 52-Week High | $60.91 |
| 52-Week Low | $22.61 |
| Volume | 1.58K |
| Avg Volume | 0 |
| Revenue (TTM) | $541.74M |
| Net Income | $88.01M |
| Gross Margin | 70.92% |
9 analysts cover VCYT: 0 strong buy, 7 buy, 1 hold, 1 sell, 0 strong sell. Consensus rating is buy. Average price target: $55.43.